Company Overview and News

30
Iamgold: Looking At Rebound Potential

6h seekingalpha
IAMGOLD shares will likely be sensitive to the gold price and look like a good momentum buy if gold prices finally have upside from the $1,200 level.
HMY ABX NEM YRI K ELD KGC AUY AEM IAG HGMCF EGO ABX

11
Tilray the king of marijuana stocks

9h thestar - 1
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
STZ.B ABX WEED CRON NVS STZ DGE DGE CGC TLRY DEO ABX

27
Harmony Gold Mining Stock Showing Strength Amid Weaker Gold Prices

11h seekingalpha
Back in June, I wrote an update on Harmony Gold Mining (HMY) following the company's equity raise near yearly lows. Currently, I'm intrigued by the possibility of a rebound in gold mining stocks as gold tries to get some upside from the $1,200 level (I've already laid out my views on Barrick Gold (ABX) (here), Agnico Eagle Mines (AEM) (here), Newmont Mining (NEM) (here), Yamana Gold (AUY) (here), Eldorado Gold (EGO) (here), Goldcorp (here), Kinross Gold (here)).
HMY ABX ELD KGC AUY NEM YRI K AEM HGMCF EGO ABX

 
Best Drill Interceptions In The Metals Mining Sector For The Week Ended 16 September 2018

14h seekingalpha
Chakana drills over 400m at 0.69% Cu, 1.45 g/t Au and 50.5 g/t Ag at Soledad.
RER SKE ABX CN WDO SKRED SKREF CNRIF WDOFF EQXGF ABX

 
3 Mining Stocks With Great Value And Downside Protection

2018-09-19 seekingalpha
GoGold is extremely cheap, even if the true potential of the tailings process is presently unknown.
ABX GLGDF AUCOY POYYF LNSTY GGD ABX

 
Ed Cope Joins NuLegacy Gold Management Team

2018-09-18 globenewswire
RENO, Nev., Sept. 18, 2018 (GLOBE NEWSWIRE) -- NuLegacy Gold Corporation (TSX-V:NUG) (OTCQX:NULGF) reports that Mr. Ed Cope, currently a director of NuLegacy Gold, will join NuLegacy’s management to both oversee exploration efforts and be responsible for property evaluation and acquisition.
ABX NULGF ABX

3
Midland annonce de nouveaux résultats aurifères significatifs sur Willbob à proximité du projet Kan d’Osisko/Barrick

2018-09-18 globenewswire
MONTRÉAL, 18 sept. 2018 (GLOBE NEWSWIRE) -- Exploration Midland inc. (« Midland ») (TSX-V: MD) a le plaisir d’annoncer de nouveaux résultats aurifères significatifs obtenus lors de sa plus récente campagne d’exploration complétée sur le projet Willbob qui est détenu à 100% par Midland. Le projet Willbob est localisé dans la Fosse du Labrador, à environ 70 km à l’ouest de Kuujjuaq. La campagne de l’été 2018 consistait en du décapage mécanique et du rainurage des meilleurs indices d’or qui avaient été découverts en 2017, en plus de travaux de prospection et de cartographie géologique à l’échelle de ce vaste projet.
ATUSF ABX IAG ABX

3
Midland Announces New Significant Gold Results on Willbob, Near the Osisko/Barrick Kan Project

2018-09-18 globenewswire
MONTREAL, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce new significant gold results obtained during its latest exploration campaign conducted on the Willbob project, wholly owned by Midland. The Willbob project is located in the Labrador Trough, approximately 70 km west of Kuujjuaq. The summer 2018 field campaign consisted in mechanical stripping and channel sampling of the best gold occurrences discovered in 2017, in addition to an extensive prospecting and geological mapping program covering the entire project.
MD ATUSF ABX ABMBF AEM ABI MDNND IAG ABX

5
How To Avoid Losing Stocks

2018-09-17 seekingalpha
Most large losers had clear characteristics in place before their declines accelerated that would have allowed traders or investors to avoid them.
ABX HRB KOR KGI KGI.DB.A KGI.DB KL CORVF ABX

2
NovaGold Resources stock price target cut to $6 from $7 at J.P. Morgan

2018-09-17 marketwatch
Newmont Mining is poised to overtake Barrick Gold as the world’s largest gold producer in 2018.
FB ABX NEM UHID UHS NG ABX SU SU

 
Rio2 Limited Corporate Update

2018-09-17 globenewswire
TORONTO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Rio2 Limited (“Rio2” or the “Company”) (TSXV: RIO; BVL:RIO) is pleased to provide a Corporate Update.
HCHDY ACPGF ABX HCHDF MALRY MARUF HOC MALRF MIN ABX

 
Third Quarter 2018 Results Release on October 24, Preliminary Third Quarter Production Results on October 10

2018-09-14 globenewswire
TORONTO, Sept. 14, 2018 (GLOBE NEWSWIRE) -- Barrick Gold Corporation (NYSE:ABX)(TSX:ABX) (“Barrick” or the “Company”) will release its Third Quarter 2018 Results on October 24, 2018, followed by a conference call and webcast on October 25 at 8:00 a.m. ET.
ABX ABX

2
PRECIOUS-Gold near 1-wk highs as Sino-U.S. trade talk hopes hurt dollar

2018-09-13 reuters
BENGALURU, Sept 13 (Reuters) - Gold prices held steady on Thursday after hitting more than one-week highs the session before, with hopes for a new round of U.S.-China trade talks weighing on the dollar.
FOSUF NGD ABX AUY YRI 0656 NGDAF NGD FOSUY ABX

2
Barrick to eliminate innovation role under decentralization

2018-09-12 reuters
TORONTO, Sept 12 (Reuters) - Barrick Gold Corp will eliminate the executive role of Chief Innovation Officer as part of a broad decentralization push, the company said on Wednesday, adding that it will continue to work on innovation and productivity improvements.
ABX CSCO ABX

10
Canadian weed stocks might be too high

2018-09-12 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
STZ.B ABX ACBFF CRON CF STZ TLRY ACB APH AAPL CCORF APHQF CF ABX

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to TSX:ABX / Barrick Gold Corporation on message board site Silicon Investor.

Barrick Gold (ABX) Barrick Gold (ABX) Barrick Gold (ABX) Blue Chip Gold Stocks HM, NEM, ASA, ABX, PDG Blue Chip Gold Stocks HM, NEM, ASA, ABX, PDG Blue Chip Gold Stocks HM, NEM, ASA, ABX, PDG
Blue Chip Gold Stocks HM, NEM, ASA, ABX, PDG (MODERATED) Blue Chip Gold Stocks HM, NEM, ASA, ABX, PDG (MODERATED) Blue Chip Gold Stocks HM, NEM, ASA, ABX, PDG (MODERATED) ABXA.ob ABX air former subsid Airborne ABXA.ob ABX air former subsid Airborne ABXA.ob ABX air former subsid Airborne